FR2620334A1 - Composition pour l'administration orale contenant du magnesium et du potassium - Google Patents

Composition pour l'administration orale contenant du magnesium et du potassium Download PDF

Info

Publication number
FR2620334A1
FR2620334A1 FR8811809A FR8811809A FR2620334A1 FR 2620334 A1 FR2620334 A1 FR 2620334A1 FR 8811809 A FR8811809 A FR 8811809A FR 8811809 A FR8811809 A FR 8811809A FR 2620334 A1 FR2620334 A1 FR 2620334A1
Authority
FR
France
Prior art keywords
potassium
magnesium
bioavailable
milliequivalents
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8811809A
Other languages
English (en)
French (fr)
Inventor
Pravin B Sheth
Frederick J Dechow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2620334A1 publication Critical patent/FR2620334A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR8811809A 1987-09-11 1988-09-09 Composition pour l'administration orale contenant du magnesium et du potassium Withdrawn FR2620334A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9575087A 1987-09-11 1987-09-11

Publications (1)

Publication Number Publication Date
FR2620334A1 true FR2620334A1 (fr) 1989-03-17

Family

ID=22253423

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8811809A Withdrawn FR2620334A1 (fr) 1987-09-11 1988-09-09 Composition pour l'administration orale contenant du magnesium et du potassium

Country Status (12)

Country Link
JP (1) JPH01100128A (da)
AU (1) AU619481B2 (da)
BE (1) BE1001842A3 (da)
CH (1) CH677612A5 (da)
DE (1) DE3830563A1 (da)
DK (1) DK501288A (da)
FR (1) FR2620334A1 (da)
GB (1) GB2209668B (da)
IT (1) IT1227010B (da)
LU (1) LU87331A1 (da)
NL (1) NL8802224A (da)
SE (1) SE8803125L (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009290A1 (en) * 1990-11-29 1992-06-11 Mills John A Treatment of exercise-induced pulmonary hemorrhage in animals
FR2677546A1 (fr) * 1991-06-12 1992-12-18 Joanny Fabienne Composition therapeutique pour liberation prolonge de magnesium.

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015611A1 (en) * 1989-06-20 1990-12-27 Otsuka Pharmaceutical Co., Ltd. Potassium-supplementing preparation
FI911038A (fi) * 1991-03-01 1992-09-02 Slk Marketing Oy Dryckpulver.
US5460972A (en) * 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
DE4201504C2 (de) * 1992-01-21 1997-04-30 Protina Chemische Ges Mbh Magnesiumpräparat
CN1090483C (zh) * 1997-07-31 2002-09-11 谢理峰 钾镁缓释片及生产方法
DE10158286B4 (de) * 2000-11-20 2007-08-02 Dehn, Michael C. Wirkstoffspeicherndes Schichtmaterial
DE10126405A1 (de) * 2001-05-22 2003-02-27 Trommsdorff Gmbh & Co Physiologisch verträgliche Kalium- und Magnesiumsalze enthaltendes pharmazeutisches Präparat sowie dessen Verwendung zur Prophylaxe und/oder Therapie von QT-Zeitverlängerungen
ATE485814T1 (de) * 2005-08-19 2010-11-15 Verla Pharm Magnesium-mikrotabletten mit verzögerter freisetzung

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2279414A1 (fr) * 1974-07-26 1976-02-20 Smith Kline French Lab Composition pharmaceutique comprenant des composes de magnesium et de potassium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA73467B (en) * 1972-02-25 1973-10-31 Hoffmann La Roche Mineral salts containing preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2279414A1 (fr) * 1974-07-26 1976-02-20 Smith Kline French Lab Composition pharmaceutique comprenant des composes de magnesium et de potassium

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009290A1 (en) * 1990-11-29 1992-06-11 Mills John A Treatment of exercise-induced pulmonary hemorrhage in animals
FR2677546A1 (fr) * 1991-06-12 1992-12-18 Joanny Fabienne Composition therapeutique pour liberation prolonge de magnesium.
WO1992022305A1 (fr) * 1991-06-12 1992-12-23 Fabienne Joanny Composition therapeutique pour liberation prolongee de magnesium

Also Published As

Publication number Publication date
AU619481B2 (en) 1992-01-30
LU87331A1 (fr) 1989-10-26
GB2209668B (en) 1991-06-05
GB2209668A (en) 1989-05-24
DK501288D0 (da) 1988-09-09
BE1001842A3 (fr) 1990-03-20
DK501288A (da) 1989-03-12
DE3830563A1 (de) 1989-03-30
IT1227010B (it) 1991-03-05
SE8803125D0 (sv) 1988-09-06
CH677612A5 (da) 1991-06-14
AU2204388A (en) 1989-03-16
SE8803125L (sv) 1989-03-12
IT8848327A0 (it) 1988-09-08
GB8821056D0 (en) 1988-10-05
JPH01100128A (ja) 1989-04-18
NL8802224A (nl) 1989-04-03

Similar Documents

Publication Publication Date Title
EP0385846B1 (fr) Composition pharmaceutique à libération prolongée d'acide valproîque
JP2740993B2 (ja) 内服用新規医薬製剤
US5238686A (en) Sustained-release pharmaceutical preparation
BE1015217A5 (da)
FR2949061A1 (fr) Microgranules flottants
EP1524969A2 (fr) Microcapsules a liberation modifiee de principes actifs peu solubles pour administration per os
BE1001842A3 (fr) Composition orale a base de potassium et de magnesium et son utilisation.
NZ274646A (en) Controlled release potassium tablets
JPH0625064B2 (ja) 制御放出塩化カリウム
AU657573B2 (en) Oral preparation for release in lower digestive tracts
US4954349A (en) Oral magnesium and potassium compositions and use
US20230263740A1 (en) Capsule for treating ulcerative colitis
FR2490493A1 (fr) Composition pharmaceutique ou alimentaire contenant de l'a -cetoglutarate de pyridoxine, procede pour sa preparation
FR2752162A1 (fr) Comprime de maleate de trimebutine pellicule
FR2540727A1 (fr) Nouvelle preparation retard contenant de la n''-cyano-n-4-pyridyl-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension
EP2731609A1 (en) Nicotinamide compositions and the therapeutic use thereof
WO1989000045A1 (en) Pellets with enzymatically controlled drug release
NO774400L (no) Fremgangsmaate til fremstilling av farmasoeytiske sammensetninger
EP0542979B1 (fr) Composition therapeutique pour liberation prolongee de magnesium
EP0445156B1 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
EP0367538A2 (en) Stabilized phytic acid compositions
BE825194A (fr) Hydrazide de n-benzene-sulfonyl-beta-alanine comme agent immunosupressif sur et actif
BE667641A (da)

Legal Events

Date Code Title Description
ST Notification of lapse